Iktos announces strategic collaboration with Cube biotech

We are thrilled to announce our strategic partnership with Cube Biotech! The synergy between Cube Biotech's advanced membrane protein technology and Iktos' AI-driven drug discovery platform will help us develop novel small molecule agonists of the Amylin Receptor — a target with transformative potential for addressing obesity, diabetes, and other cardiometabolic disorders.

Click here to access our press release.